Literature DB >> 22408716

Number of lymph nodes after neoadjuvant therapy for rectal cancer: How many are needed?

Stefano Scabini1, Valter Ferrando.   

Abstract

Neoadjuvant chemoradiation is the standard treatment for advanced rectal tumor, providing better local control of disease and potentially increasing sphincter preservation surgery. Neoadjuvant radiation may affect the number of lymph nodes harvested after resection or alter their prognostic value. Over the past 10 years, standards for lymph node harvests in colorectal cancer have been proposed. Several studies have recommend examination of at least 12 lymph nodes (LNs) in the specimen and this number is now used as a reflection of surgical quality. Nevertheless, recent reports have identified significantly decreased LN harvests in patients treated with neoadjuvant radiation. And preoperative chemoradiation has a significant effect on the number of nodes harvested in rectal specimens and this should be considered in staging of the tumor. In the near future, the total number of nodes will be less important than specific biologic markers in detecting high-risk patients and improving their prognosis with adjuvant therapy tailored.

Entities:  

Keywords:  Lymphnodes; Neoadjuvant therapy; Rectal cancer

Year:  2012        PMID: 22408716      PMCID: PMC3297665          DOI: 10.4240/wjgs.v4.i2.32

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  28 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum.

Authors:  Friedrich Prall; Michael Wöhlke; Gunther Klautke; Leif Schiffmann; Rainer Fietkau; Malte Barten
Journal:  APMIS       Date:  2006-03       Impact factor: 3.205

3.  Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum.

Authors:  Mary Kay Washington; Jordan Berlin; Philip A Branton; Lawrence J Burgart; David K Carter; Patrick L Fitzgibbons; Wendy L Frankel; John M Jessup; Sanjay Kakar; Bruce Minsky; Raouf E Nakhleh; Carolyn C Compton
Journal:  Arch Pathol Lab Med       Date:  2008-07       Impact factor: 5.534

4.  Lymph node evaluation as a colon cancer quality measure: a national hospital report card.

Authors:  Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; Mark S Talamonti; David P Winchester; Thomas R Russell; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

5.  No downstaging after short-term preoperative radiotherapy in rectal cancer patients.

Authors:  C A Marijnen; I D Nagtegaal; E Klein Kranenbarg; J Hermans; C J van de Velde; J W Leer; J H van Krieken
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

6.  Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist.

Authors:  Eva Judith Ann Morris; Nicola Joanne Maughan; David Forman; Philip Quirke
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

7.  Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.

Authors:  Dow-Mu Koh; Ian Chau; Diana Tait; Andrew Wotherspoon; David Cunningham; Gina Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

8.  The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Authors:  Frédérique Peschaud; Peschaud Frédérique; Stéphane Benoist; Benoist Stéphane; Catherine Julié; Julié Catherine; Alain Beauchet; Beauchet Alain; Christophe Penna; Penna Christophe; Philippe Rougier; Rougier Philippe; Bernard Nordlinger
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

9.  The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.

Authors:  Young-Wan Kim; Nam-Kyu Kim; Byung-Soh Min; Kang-Young Lee; Seung-Kook Sohn; Chang-Hwan Cho
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

10.  Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean?

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Viviane Rawet; Diego D Pereira; Afonso H S Sousa; Desiderio Kiss; Ivan Cecconello
Journal:  Dis Colon Rectum       Date:  2008-03       Impact factor: 4.585

View more
  5 in total

1.  Ex Vivo Intra-arterial Methylene Blue Injection in Rectal Cancer Specimens Increases the Lymph-Node Harvest, Especially After Preoperative Radiation.

Authors:  Maria Münster; Uwe Hanisch; Muin Tuffaha; Rainer Kube; Henry Ptok
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

2.  Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.

Authors:  M J Fernández-Aceñero; M Granja; J Sastre; B García-Paredes; L Estrada
Journal:  Virchows Arch       Date:  2016-01-11       Impact factor: 4.064

3.  Preoperative chemoradiation therapy decreases the number of lymph nodes resected during esophagectomy.

Authors:  Adamu Issaka; Nezih Onur Ermerak; Zeynep Bilgi; Volkan Hasan Kara; Cigdem Ataizi Celikel; Hasan Fevzi Batirel
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

4.  What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer.

Authors:  Won-Suk Lee; Seok Ho Lee; Jeong-Heum Baek; Woon Kee Lee; Jung Nam Lee; Na Rae Kim; Yeon Ho Park
Journal:  Radiat Oncol       Date:  2013-08-19       Impact factor: 3.481

5.  Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital.

Authors:  Christian Galata; Kirsten Merx; Sabine Mai; Timo Gaiser; Frederik Wenz; Stefan Post; Peter Kienle; Ralf-Dieter Hofheinz; Karoline Horisberger
Journal:  World J Surg Oncol       Date:  2018-08-02       Impact factor: 3.253

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.